| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |